Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy

PURPOSE: Metastatic renal cell carcinoma (RCC) is one of the most treatment-resistant malignancies and nephrectomy, isolated or combined with systemic chemotherapy typically has limited or no effectiveness. We report our initial results in patients treated with the association of molecular targeted...

Full description

Bibliographic Details
Main Authors: Marcos F. Dall'Oglio, Juliana M. Sousa-Canavez, Fabio Y. Tanno, Bruno C. Tiseo, Alexandre Crippa, Sabrina T. dos Reis, Katia R. M. Leite, Miguel Srougi
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2011-04-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000200004